This hypothesis was confirmed by treating PPARγ siRNA transfected PPARγ positive MCF-7 and MDA-MB-231 human breast cancer cells with similar doses of γ-tocotrienol, PPARγ agonists, and antagonists alone and in combination. The gene discussed is PPARG; the disease is breast cancer.